Indications for how and when to treat low grade gliomas;Quand et comment traiter un « gliome de bas grade »?

Revue Neurologique

Volumn 160, Issue 5 I, 2004, Pages 507-509

  Honnorat, J ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTISONE;

ASTROCYTOMA; BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CHROMOSOME 19P; CHROMOSOME 1P; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EDITORIAL; EPILEPSY; GLIOMA; HISTOLOGY; HUMAN; INTRACRANIAL HYPERTENSION; OLIGODENDROGLIOMA; TREATMENT INDICATION;

EID: 2942741224     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(04)70979-0     Document Type: Editorial

References (19)

1. BRADA M, VIVIERS L, ABSON C et al. (2003). Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol, 14: 1715-1721.
2. BROWN PD, BUCKNER JC, O'FALLON JR et al. (2003). Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol, 21: 2519-2524.
3. BUCKNER JC, GESME D JR, O'FALLON JR et al. (2003). Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol, 21: 251-255.
4. CAIRNCROSS JG, MACDONALD DR. (1988). Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol, 23: 360-364.
5. CAIRNCROSS JG, UEKI K, ZLATESCU MC et al. (1998). Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst, 90: 1473-1479.
6. COONS SW, JOHNSON PC, SCHEITHAUER BW, YATES AJ, PEARL DK. (1997). Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer, 79: 1381-1393.
7. DAUMAS-DUPORT C. (2000). The future of neuropathology. Clin Neurosurg, 47: 112-120.
8. KARIM AB, MAAT B, HATLEVOLL R et al. (1996). A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys, 36: 549-556.
9. KARIM AB, AFRA D, CORNU P et al. (2002). Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52: 316-324.
10. KELES GE, LAMBORN KR, BERGER MS. (2001). Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg, 95: 735-745.
11. LOPES M, DUFFAU H, CAPELLE L, MENINGAUD JP, HERVE C. (2002). Quelle est l'attitude des neurochirurgiens français face à un patient porteur d'un gliome de bas grade? Neurochirurgie, 48: 69-74.
12. MACDONALD DR, CASCINO TL, SCHOLD SC JR, CAIRNCROSS JG. (1990). Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol, 8: 1277-1280.
13. MASON WP, KROL GS, DEANGELIS LM. (1996). Low-grade oligodendroglioma responds to chemotherapy. Neurology, 46: 203-207.
14. PACE A, VIDIRI A, GALIE E et al. (2003). Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol, 14: 1722-1726.
15. POIRIER J. (2000). Les oligodendrogliomes revisités. Rev Neurol (Paris), 156: 219-221.
16. QUINN JA, REARDON DA, FRIEDMAN AH et al. (2003). Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol, 21: 646-651.
17. SHAW EG, ARUSSEL R, SCHEITHAUER B et al. (2002). A prospective randomized trial of low-versus high dose radiation therapy in adults with supratentorial low grade glioma: initial report of NCCTG-RTOG-ECOG study. J Clin Oncol, 20: 2267-2276.
18. STEIGER HJ, MARKWALDER RV, SEILER RW, EBELING U, REULEN HJ. (1990). Early prognosis of supratentorial grade 2 astrocytomas in adult patients after resection or stereotactic biopsy. An analysis of 50 cases operated on between 1984 and 1988. Acta Neurochir, 106: 99-105.
19. WESSELS PH, WEBER WE, RAVEN G, RAMAEKERS FC, HOPMAN AH, TWIJNSTRA A. (2003). Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol, 2: 395-403.